These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

432 related articles for article (PubMed ID: 38256050)

  • 21. The use of stem cells in regenerative medicine for Parkinson's and Huntington's Diseases.
    Lescaudron L; Naveilhan P; Neveu I
    Curr Med Chem; 2012; 19(35):6018-35. PubMed ID: 22963567
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeted Delivery for Neurodegenerative Disorders Using Gene Therapy Vectors: Gene Next Therapeutic Goals.
    Singh M; Singh SP; Yadav D; Agarwal M; Agarwal S; Agarwal V; Swargiary G; Srivastava S; Tyagi S; Kaur R; Mani S
    Curr Gene Ther; 2021; 21(1):23-42. PubMed ID: 32811395
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical utility of neuroprotective agents in neurodegenerative diseases: current status of drug development for Alzheimer's, Parkinson's and Huntington's diseases, and amyotrophic lateral sclerosis.
    Dunkel P; Chai CL; Sperlágh B; Huleatt PB; Mátyus P
    Expert Opin Investig Drugs; 2012 Sep; 21(9):1267-308. PubMed ID: 22741814
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mitochondrial dysfunction and oxidative stress in Alzheimer's disease, and Parkinson's disease, Huntington's disease and Amyotrophic Lateral Sclerosis -An updated review.
    Alqahtani T; Deore SL; Kide AA; Shende BA; Sharma R; Dadarao Chakole R; Nemade LS; Kishor Kale N; Borah S; Shrikant Deokar S; Behera A; Dhawal Bhandari D; Gaikwad N; Kalam Azad A; Ghosh A
    Mitochondrion; 2023 Jul; 71():83-92. PubMed ID: 37269968
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MicroRNA Alteration, Application as Biomarkers, and Therapeutic Approaches in Neurodegenerative Diseases.
    Nguyen TPN; Kumar M; Fedele E; Bonanno G; Bonifacino T
    Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563107
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regenerative medicine improve neurodegenerative diseases.
    Ashraf SS; Hosseinpour Sarmadi V; Larijani G; Naderi Garahgheshlagh S; Ramezani S; Moghadamifar S; Mohebi SL; Brouki Milan P; Haramshahi SMA; Ahmadirad N; Amini N
    Cell Tissue Bank; 2023 Sep; 24(3):639-650. PubMed ID: 36527565
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gut-Brain Axis Deregulation and Its Possible Contribution to Neurodegenerative Disorders.
    Villavicencio-Tejo F; Olesen MA; Navarro L; Calisto N; Iribarren C; García K; Corsini G; Quintanilla RA
    Neurotox Res; 2023 Dec; 42(1):4. PubMed ID: 38103074
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exploring the Role of Stem Cell Therapy in Treating Neurodegenerative Diseases: Challenges and Current Perspectives.
    Puranik N; Arukha AP; Yadav SK; Yadav D; Jin JO
    Curr Stem Cell Res Ther; 2022; 17(2):113-125. PubMed ID: 35135462
    [TBL] [Abstract][Full Text] [Related]  

  • 29. microRNAs and Neurodegenerative Diseases.
    Qiu L; Tan EK; Zeng L
    Adv Exp Med Biol; 2015; 888():85-105. PubMed ID: 26663180
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stem cell in neurodegenerative disorders; an emerging strategy.
    Ahani-Nahayati M; Shariati A; Mahmoodi M; Olegovna Zekiy A; Javidi K; Shamlou S; Mousakhani A; Zamani M; Hassanzadeh A
    Int J Dev Neurosci; 2021 Jun; 81(4):291-311. PubMed ID: 33650716
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of colony stimulating factor-1 receptor (CSF-1R) as a potential therapeutic strategy for neurodegenerative diseases: opportunities and challenges.
    Han J; Chitu V; Stanley ER; Wszolek ZK; Karrenbauer VD; Harris RA
    Cell Mol Life Sci; 2022 Apr; 79(4):219. PubMed ID: 35366105
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Therapeutic potential of human adipose-derived stem cells in neurological disorders.
    Chang KA; Lee JH; Suh YH
    J Pharmacol Sci; 2014; 126(4):293-301. PubMed ID: 25409785
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The potential of alternate sources of cells for neural grafting in Parkinson's and Huntington's disease.
    Drouin-Ouellet J
    Neurodegener Dis Manag; 2014; 4(4):297-307. PubMed ID: 25313986
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Therapeutics for neurodegenerative diseases by targeting the gut microbiome: from bench to bedside.
    Ma YY; Li X; Yu JT; Wang YJ
    Transl Neurodegener; 2024 Feb; 13(1):12. PubMed ID: 38414054
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunomodulatory effects of stem cells: Therapeutic option for neurodegenerative disorders.
    Caprnda M; Kubatka P; Gazdikova K; Gasparova I; Valentova V; Stollarova N; La Rocca G; Kobyliak N; Dragasek J; Mozos I; Prosecky R; Siniscalco D; Büsselberg D; Rodrigo L; Kruzliak P
    Biomed Pharmacother; 2017 Jul; 91():60-69. PubMed ID: 28448871
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vitamin E and neurodegenerative disorders associated with oxidative stress.
    Butterfield DA; Castegna A; Drake J; Scapagnini G; Calabrese V
    Nutr Neurosci; 2002 Sep; 5(4):229-39. PubMed ID: 12168685
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stem cell challenges in the treatment of neurodegenerative disease.
    Feng Z; Gao F
    CNS Neurosci Ther; 2012 Feb; 18(2):142-8. PubMed ID: 22070610
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Immune System and Neuroinflammation as Potential Sources of Blood-Based Biomarkers for Alzheimer's Disease, Parkinson's Disease, and Huntington's Disease.
    Clark LF; Kodadek T
    ACS Chem Neurosci; 2016 May; 7(5):520-7. PubMed ID: 27046268
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of extracellular vesicles in neurodegenerative diseases.
    Xiao Y; Wang SK; Zhang Y; Rostami A; Kenkare A; Casella G; Yuan ZQ; Li X
    Prog Neurobiol; 2021 Jun; 201():102022. PubMed ID: 33617919
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The use of fibroblasts as a valuable strategy for studying mitochondrial impairment in neurological disorders.
    Olesen MA; Villavicencio-Tejo F; Quintanilla RA
    Transl Neurodegener; 2022 Jul; 11(1):36. PubMed ID: 35787292
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.